Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting is one of the more unpleasant but well-documented side effects of tirzepatide. It tends to arrive in the first few weeks of treatment or after a dose increase, and for most people it settles within days as the body adjusts. That pattern is consistent with how the medicine works: tirzepatide slows gastric emptying and increases satiety signals, which the gut can find unsettling at first. It is a Prescription-Only Medicine, and if throwing up on Mounjaro is affecting your ability to keep food or fluids down, your prescriber is the right person to guide you through it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The stomach takes time to learn Mounjaro's rhythm. Tirzepatide activates both GIP and GLP-1 receptors, which slows the rate at which food leaves the stomach. If the stomach is full, or if you've eaten quickly, or if a meal was high in fat, that delayed emptying can tip into vomiting. Understanding the trigger is the first practical step, because it is usually something changeable.
Common culprits include eating too fast, serving yourself a normal-sized portion when your appetite is already blunted, drinking liquids with food rather than between meals, and eating heavy or greasy foods. People often notice that throwing up on Mounjaro happens within an hour of a meal rather than out of the blue.
Keeping a brief note of what you ate and when symptoms started helps you (and your prescriber) spot the pattern. The tirzepatide overview on this site covers the mechanism in more detail if you want to understand what's happening physiologically. The short version: your system is recalibrating, and that takes time.
This is where most people find the biggest improvement. Small, frequent meals work better than three large ones. Eating slowly, stopping before you feel full, and chewing thoroughly all reduce the load on a stomach that is already emptying more slowly than usual.
Bland, low-fat foods are easier to tolerate: plain rice, toast, boiled chicken, soup, crackers. Avoid very rich dishes, anything fried, and alcohol, all of which slow gastric emptying further. Keep portions to roughly half of what you'd normally eat and see whether that helps.
Hydration matters a great deal here. Vomiting depletes fluids quickly, and dehydration can make nausea worse. Small, frequent sips of water or diluted juice throughout the day are more effective than large glasses. Cold or room-temperature fluids tend to sit better than hot ones.
If you are also thinking about the cost of treatment while managing side effects, our Mounjaro pricing page lays out what a private prescription typically covers and what to watch for when comparing providers.
Most vomiting on Mounjaro is uncomfortable but not dangerous. There are circumstances, though, where it crosses into a clinical concern that needs same-day attention.
Contact a healthcare professional promptly if you cannot keep fluids down for more than 24 hours, if you are showing signs of dehydration (dark urine, dizziness when standing, a dry mouth that won't clear), or if you notice blood in your vomit. The other urgent signal is severe, persistent stomach pain that spreads to the back, with or without vomiting: the MHRA issued a Drug Safety Update in January 2026 reminding patients and clinicians that acute pancreatitis is a known but infrequent side effect of GLP-1 medicines that can present this way. It's rare, but it's the kind of symptom you don't wait out.
If symptoms are disruptive but not urgent, your prescriber may be able to slow the titration schedule, keep you at your current dose for longer, or advise on anti-nausea measures. That conversation is worth having. A question our prescribers hear regularly is whether vomiting means treatment has to stop; usually, it does not.
Mounjaro is a prescription-only medicine, and dose changes, extensions to the titration timeline, and decisions about pausing or stopping treatment all sit with your prescriber. Self-managing by skipping doses without guidance is not recommended: inconsistent dosing can make nausea worse rather than better, and the NHS tirzepatide patient information page advises referring to the Patient Information Leaflet and speaking to a pharmacist or GP if side effects become a problem.
If weight loss is slowing at the same time as you are dealing with side effects, that is a connected question worth raising too; the page on weight loss slowing on Mounjaro covers the reasons that can happen. For people who are still exploring whether they want to start treatment, our prescribers review consultations on the same day they are submitted, Monday to Friday. If you ordered before 12pm on a Friday and then spent the weekend googling side effects, that is a very common order of events. If you are currently weighing up your options, the information on getting Mounjaro through your GP may help you decide which route suits your circumstances best.
Anyone experiencing an unusual symptom alongside vomiting, such as discomfort in the throat or a lump-like sensation when swallowing, can find information on the throat and swallowing effects associated with tirzepatide, or read more about the lump-in-throat sensation some people report. These are distinct from vomiting but occasionally co-occur in the early weeks of treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.